Hisataka Kobayashi

64PUBLICATIONS
45CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)NanophotonicsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|May 19, 2026
Human epidermal growth factor receptor 3-targeted near-infrared photoimmunotherapy in a xenograft mouse model of breast cancer.

|Dec 18, 2025
Combined CD25-targeted near infrared photoimmunotherapy (NIR-PIT) and intratumor IL-15 enhance the effectiveness of anti-PD-1 immunotherapy.

Makoto Kano, Aki Furusawa, Hiroshi Fukushima

|Nov 13, 2025
CD271 Targeted Near-Infrared Photoimmunotherapy for Local Depletion of Cancer Stem Cells.

Ryosuke Takahashi, Atsushi Kaida, Hitomi Nojima

|Oct 13, 2025
Response to Letter regarding EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer.

Aki Furusawa, Hisataka Kobayashi

|Aug 31, 2025
Interleukin 15 (IL15)-based near-infrared photoimmunotherapy.

Motofumi Suzuki, Aki Furusawa, Hiroshi Yamamoto

|Aug 12, 2025
EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer.

Aki Furusawa, Seiichiro Takao, Motofumi Suzuki

Pageof 11

Frequent Collaborators

19 joint publications

Aki Furusawa

13 joint publications

Peter L Choyke

12 joint publications

Ryuhei Okada

10 joint publications

Hiroaki Wakiyama